On Tuesday, Seventy Seven Energy Inc (NYSE:SSE)’s shares declined -0.28% to $3.50.
Aveda Transportation and Energy Services Inc. a leading provider of oilfield hauling services and equipment rentals to the energy industry, recently declared that, through its operating partner in the US, it has accomplished the acquisition of Hodges Trucking Company, L.L.C. (“Hodges”), from an associate of Seventy Seven Energy Inc. (SSE). The purchase price was US$42.0 million. US$15.0 million of the purchase price is financed through the Company’s existing senior credit facility and US$27.0 million is financed by a seller take-back note (the “Note”). The Note is a 5 year term debt note with no requirement for principal amortization. The Note bears interest at 9% per annum which interest shall be paid quarterly. The Note is secured by a 2nd lien on the Company’s fixed assets and accounts receivable. The Company anticipates to provide further details and an operation update later this week.
Seventy Seven Energy Inc. provides oilfield services in the United States. The company operates in four segments: Drilling, Hydraulic Fracturing, Oilfield Rentals, and Oilfield Trucking. The Drilling segment offers land drilling and drilling-related services, counting directional drilling for the oil and natural gas exploration and development activities. The Hydraulic Fracturing segment provides hydraulic fracturing and other well stimulation services.
NextEra Energy Inc (NYSE:NEE)’s shares gained 2.42% to $102.89.
Silagy has been with FPL and its parent company NextEra Energy Inc (NEE), Florida Power & Light Company (FPL) declared that its President and Chief Executive Officer Eric Silagy has been designated to the U.S. Chamber of Commerce Board of Directors for a two-year term. Silagy joins an influential group of 100 business leaders who champion the interests of more than 3 million businesses of all sizes, sectors and regions.
NextEra Energy, Inc., through its auxiliaries, generates, transmits, and distributes electric energy in the United States and Canada. The company generates electricity from gas, oil, solar, coal, petroleum coke, nuclear, and wind sources. As of December 31, 2014, it served about 9 million people through about 4.7 million customer accounts in the east and lower west coasts of Florida.
At the end of Tuesday’s trade, Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)‘s shares surged 0.59% to $187.33.
Alexion Pharmaceuticals, Inc. (ALXN) declared that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved the Company’s New Drug Application (NDA) for the use of Strensiq® (asfotase alfa) as a treatment for patients in Japan with hypophosphatasia (HPP), a life-threatening, ultra-rare metabolic disorder. Strensiq, a bone-targeted enzyme replacement therapy, is the first therapy approved in Japan for the treatment of patients with HPP. Alexion anticipates that initial patients with HPP in Japan will start commercial treatment with Strensiq by late Q3 2015.
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. The company also conducts Phase IV clinical trials on Soliris for the treatment of PNH and aHUS registry; Phase III clinical trials for the treatment of delayed kidney transplant graft function and myasthenia gravis; and Phase II clinical trials for the treatment of antibody mediated rejection in presensitized kidney transplant patients and neuromyelitis optica.
HCP, Inc. (NYSE:HCP), ended its Tuesday’s trading session with 2.21% gain, and closed at $37.96.
HCP (HCP) will report its second quarter 2015 financial results on Tuesday, August 4, 2015, before the open of trading on the New York Stock Exchange. HCP will also host a conference call and webcast at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) that same day in order to review its financial performance and operating results for the quarter ended June 30, 2015.
HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. It primarily invests in properties serving the healthcare industry counting sectors of healthcare such as senior housing, life science, medical office, hospital and skilled nursing. T
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
